P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY
Neha Mehta-Shah,
Eric Jacobsen,
Pier Luigi Zinzani,
Jasmine Zain,
Monica Mead,
Carla Casulo,
Giuseppi Gritti,
Lauren Pinter-Brown,
Koji Izutsu,
Sheila Waters,
Jonathan Brammer,
Barbara Pro,
Steven Horwitz
Affiliations
Neha Mehta-Shah
1 Washington University School of Medicine in St. Louis, Saint Louis, United States
Eric Jacobsen
2 Dana-Farber Cancer Institute, Boston, United States
Pier Luigi Zinzani
3 Institute of Hematology Seràgnoli University of Bologna, Bologna, Italy
Jasmine Zain
4 City of Hope Medical Center, Duarte, United States
Monica Mead
5 UCLA Santa Monica Medical Center, Santa Monica, United States
Carla Casulo
6 University of Rochester, Rochester, United States
Giuseppi Gritti
7 ASST Papa Giovanni XXIII Hospital, Bergamo, Italy
Lauren Pinter-Brown
8 University of California Irvine, Irvine, United States
Koji Izutsu
9 National Cancer Center Hospital, Chuo City, Tokyo, Japan
Sheila Waters
10 Secura Bio, Inc., Las Vegas, United States
Jonathan Brammer
11 The Ohio State University, Columbus, United States
Barbara Pro
12 Columbia University Herbert Irving Medical Center, New York, United States
Steven Horwitz
13 Memorial Sloan Kettering Cancer Center New York, New York, United States
